Prime Medicine (PRME) Total Liabilities (2021 - 2026)

Prime Medicine's Total Liabilities history runs 6 years deep, the most recent figure standing at $218.0 million for Q1 2026.

• Quarterly Total Liabilities fell 1.45% year-over-year to $218.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $218.0 million (down 1.45% YoY) and the FY2025 annual result came in at $221.9 million, up 53.69% from the prior year.
• Total Liabilities was $218.0 million for Q1 2026 at Prime Medicine, down from $221.9 million in the prior quarter.
• Across five years, Total Liabilities topped out at $223.2 million in Q3 2025 and bottomed at $38.1 million in Q1 2023.
• A 5-year average of $119.5 million and a median of $67.6 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities dropped 29.3% — and 2025, when it surged 245.63%.
• Prime Medicine's Total Liabilities stood at $44.0 million in 2022, then soared by 38.0% to $60.8 million in 2023, then soared by 137.51% to $144.4 million in 2024, then soared by 53.69% to $221.9 million in 2025, then slipped by 1.73% to $218.0 million in 2026.
• Business Quant data shows PRME's Total Liabilities at $218.0 million in Q1 2026, $221.9 million in Q4 2025, and $223.2 million in Q3 2025.